Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Complying with Occupational Safety and Health Administration Regulations: A Guide for Compounding Pharmacists

Author(s):  Mixon Bill, Nain John

Issue:  May/Jun 2013 - Volume 17, Number 3
View All Articles in Issue

Page(s):  182-190

Complying with Occupational Safety and Health Administration Regulations: A Guide for Compounding Pharmacists Page 1
Complying with Occupational Safety and Health Administration Regulations: A Guide for Compounding Pharmacists Page 2
Complying with Occupational Safety and Health Administration Regulations: A Guide for Compounding Pharmacists Page 3
Complying with Occupational Safety and Health Administration Regulations: A Guide for Compounding Pharmacists Page 4
Complying with Occupational Safety and Health Administration Regulations: A Guide for Compounding Pharmacists Page 5
Complying with Occupational Safety and Health Administration Regulations: A Guide for Compounding Pharmacists Page 6
Complying with Occupational Safety and Health Administration Regulations: A Guide for Compounding Pharmacists Page 7
Complying with Occupational Safety and Health Administration Regulations: A Guide for Compounding Pharmacists Page 8
Complying with Occupational Safety and Health Administration Regulations: A Guide for Compounding Pharmacists Page 9

Download in electronic PDF format for $75

Abstract:  In the compounding pharmacy, compliance with Occupational Safety and Health Administration regulations is essential to protect employees and customers from exposure to hazardous substances and a dangerous environment, to avert heavy fines and penalties levied for noncompliance, and to fulfill the moral obligation of pharmacists to do no harm. Without adequate vigilance, compounders are vulnerable to lapses in adherence to Occupational Safety and Health Administration requirements, the results of which can be dire in a climate of increased scrutiny about the safety and integrity of pharmaceutical compounding. Proactively addressing necessary compliance with essential safety regulations can only benefit compounders and their staff and clients, and guidance from an expert in Occupational Safety and Health Administration requirements can be a key factor in accomplishing that goal.

Related Keywords: Bill Mixon, RPh, John Nain, MS, CSP, U.S. Occupational Safety and Health Administration, OSHA standards, employee health, worker protection, workplace safety, hazardous chemicals, regulatory violations, certified safety professional, chemical hygiene, respiratory protection, compliance plans, chemical labeling, fire protection, emergency action plan, loss prevention audit checklist, risk management, environmental contamination, staff training

Related Categories: ENVIRONMENTAL , LEGAL, SUPPORT, QUALITY CONTROL, PROFESSIONAL ISSUES, HAZARDOUS DRUGS

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Complying with Occupational Safety and Health Administration Regulations: A Guide for Compounding Pharmacists
Mixon Bill
, Nain John
May/Jun 2013
Pg. 182-190

Safety Standards in Pharmaceutical Compounding, Part 1: The Occupational Safety and Health Administration
Greeson Nicole MH
, Mixon William, Allan W Chris
Jul/Aug 2020
Pg. 270-276

Safety Standards in Pharmaceutical Compounding, Part 3: Fire Safety
Allen W Chris
, Greeson Nicole MH, Mixon William
Nov/Dec 2020
Pg. 451-458

Safety Standards in Pharmaceutical Compounding, Part 2: A Closer Look at Agency Information, Oversight, and Assistance
Greeson Nicole MH
, Mixon William, Allan W Chris
Sep/Oct 2020
Pg. 371-379

Healthful Living: Good Practices for Good Health
Jackson Kathy
May/Jun 2002
Pg. 164-166

Women's Oral Health: Is There a Hormonal Link?
Preckshot John
Jan/Feb 2004
Pg. 10-14

Pharmacies on the Frontline: Responding to the COVID-19 Pandemic
McElhiney Linda F
Jul/Aug 2020
Pg. 287-295

Basics of Compounding for Hazardous Drugs, Part 2: Regulation and Sources of Contamination
Allen Loyd V Jr
Nov/Dec 2006
Pg. 446-448

Quality Control: (Material) Safety Data Sheets
Allen Loyd V Jr
Mar/Apr 2017
Pg. 118-124

How to Develop and Maintain a Hazardous Drug List
Dillon L Rad
May/Jun 2019
Pg. 182-186

U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies
Yoch Doug
Mar/Apr 2017
Pg. 95-102

Safety for Employees in the Compounding Work Area
Allen Loyd V Jr
Jan/Feb 2002
Pg. 60-61

IACP Legislative/Regulatory Update: The International Academy of Compounding Pharmacists Testifies at U.S. House of Representatives' Energy & Commerce Health Subcommittee Pharmacy Compounding Hearing
Blankenship Cynthia
Mar/Apr 2018
Pg. 125-126

Development of Stable and Simple Finasteride 333-μg/mL Suspensions that Minimize Occupational Exposure
Ma Nathan
, Perks William, Law Shirley, Iazzetta John, Walker Scott
Nov/Dec 2020
Pg. 519-527

Preventing Nonmicrobiologic Airborne Contamination in the Compounding Pharmacy: Ensuring a Safe Environment for Compounders, Staff, and Clients
Mixon Bill
, Ille Gary
Jul/Aug 2009
Pg. 290-294

The U.S. Food and Drug Administration Responds to the International Academy of Compounding Pharmacists' Outsourcing Letter
Miller David G
May/Jun 2014
Pg. 208

Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations
Ashe Krystina
, Baskett Dustin
Sep/Oct 2018
Pg. 387-398

The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women
Stephenson Kenna
, Neuenschwander Pierre F, Kurdowska Anna K
Jan/Feb 2013
Pg. 74-85

View Sample
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances
Miller David G
Jul/Aug 2015
Pg. 303-305

Major Study Affirming the Relative Safety of Testosterone-replacement Therapy
Biundo Bruce
Sep/Oct 2023
Pg. 358-360

Return to Top